{"id":130,"date":"2015-10-09T16:46:20","date_gmt":"2015-10-09T16:46:20","guid":{"rendered":"http:\/\/broker.commercegurus.com\/?page_id=130"},"modified":"2018-11-14T09:25:57","modified_gmt":"2018-11-14T09:25:57","slug":"power-energy","status":"publish","type":"page","link":"https:\/\/www.thofudiagnostics.com\/?page_id=130","title":{"rendered":"ALERE DETERMINE\u2122 HIV-1\/2 AG\/AB COMBO"},"content":{"rendered":"
[vc_row type=”container” padding_top=”” padding_bottom=”” css=”.vc_custom_1449060063467{margin-bottom: 20px !important;}”][vc_column width=”1\/2″][vc_column_text]Introducing the first FDA approved rapid point-of-care test that detects both HIV-1\/2 antibodies and free HIV-1 p24 antigen. This 4th generation test has the ability to identify HIV earlier than 2nd and 3rd generation antibody-only tests.1<\/sup>\u00a0It enables health care providers to diagnose HIV infection earlier allowing individuals to seek medical care sooner.<\/p>\n Now CLIA-Waived for fingerstick whole blood!<\/strong>[\/vc_column_text][\/vc_column][vc_column width=”1\/2″ css=”.vc_custom_1449059997398{margin-bottom: 35px !important;}”][vc_single_image image=”70938″ img_size=”full” add_caption=”yes” onclick=”link_image”][\/vc_column][\/vc_row][vc_row type=”container” padding_top=”” padding_bottom=”” css=”.vc_custom_1449060013623{margin-bottom: 0px !important;}”][vc_column][vc_separator color=”#e2e2e2″ type=”normal” thickness=”1″ up=”” down=”” el_class=”dotted”][\/vc_column][\/vc_row][vc_row type=”container” padding_top=”” padding_bottom=””][vc_column][vc_column_text]<\/p>\n CLIA-waived for fingerstick whole blood<\/p>\n It\u2019s the first 4th generation rapid point-of-care test that detects both HIV-1\/2 antibodies and free HIV-1 p24 antigen on a single test strip.<\/p>\n Built-in quality controls to let you know the test is working.<\/p>\n Test in three simple steps with clear results in just 20 minutes.<\/p>\n A 4th generation test, with the ability to detect HIV earlier than 2nd and 3rd generation antibody-only tests.1<\/sup><\/p>\n Test using whole blood, serum or plasma samples.<\/p>\n Proved 99.9% overall clinical sensitivity for all sample types.<\/p>\n<\/div>\n<\/div>\nBENEFITS<\/h2>\n
INNOVATIVE<\/h3>\n
DEPENDABLE<\/h3>\n
EFFICIENT<\/h3>\n
NEXT GENERATION<\/h3>\n
FLEXIBLE<\/h3>\n
RELIABLE<\/h3>\n